Abstract

Naturally occurring (+)-spirotenuipesines A and B are known to promote the biosynthesis of neurotrophic factors in glial cells. Therefore, these compounds can be expected to constitute promising drug leads for neurodegenerative diseases such as Alzheimer's disease. In order to obtain sufficient amounts for biological evaluation, (±)-spirotenuipesine A was synthesized via a stereoselective Ireland-Claisen rearrangement as a key step. A culture medium of 1321N1 cells treated with the obtained synthetic racemic compound showed differentiation-inducing activity against PC12 cells, resulting in a morphological change.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.